The new facility will produce up to 100 million mRNA doses a year, creating 150 jobs, as US anti-vaccine rhetoric raises concerns over future investment
We use cookies to better understand how visitors interact with our website and to improve your experience.
By continuing to use this website, you agree to our use of cookies.